CGH
SEM

Crossmark Global Holdings’s Select Medical SEM Stock Holding History

Crossmark Global Holdings’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,535
Closed -$292K – 1283
2024
Q3 		$292K Buy
15,535
+39
+0.3% +$747 0.01% 1090
2024
Q2 		$293K Sell
15,496
-402
-3% -$6.86K 0.01% 1079
2024
Q1 		$258K Sell
15,898
-310
-2% -$4.54K ﹤0.01% 1160
2023
Q4 		$205K Sell
16,208
-1,392
-8% -$17.6K ﹤0.01% 1245
2023
Q3 		$231K Sell
17,600
-49
-0.3% -$757 0.01% 1147
2023
Q2 		$285K Sell
17,649
-1,412
-7% -$21.9K 0.01% 1096
2023
Q1 		$265K Sell
19,061
-965
-5% -$14.2K 0.01% 1096
2022
Q4 		$267K Sell
20,026
-1,392
-6% -$18K 0.01% 1066
2022
Q3 		$255K Sell
21,418
-483
-2% -$6.86K 0.01% 1069
2022
Q2 		$279K Hold
21,901
– – 0.01% 1058
2022
Q1 		$283K Buy
21,901
+204
+0.9% +$2.69K 0.01% 1167
2021
Q4 		$344K Buy
21,697
+1,058
+5% +$18.1K 0.01% 1085
2021
Q3 		$402K Sell
20,639
-222
-1% -$4.41K 0.01% 1030
2021
Q2 		$475K Sell
20,861
-1,151
-5% -$23.9K 0.01% 954
2021
Q1 		$404K Hold
22,012
– – 0.01% 1010
2020
Q4 		$328K Sell
22,012
-613
-3% -$8K 0.01% 1046
2020
Q3 		$254K Buy
22,625
+130
+0.6% +$1.28K 0.01% 1103
2020
Q2 		$179K Sell
22,495
-2,858
-11% -$23.7K 0.01% 1258
2020
Q1 		$205K Hold
25,353
– – 0.01% 1051
2019
Q4 		$319K Buy
25,353
+19
+0.1% +$205 0.01% 1081
2019
Q3 		$226K Sell
25,334
-557
-2% -$4.87K 0.01% 1209
2019
Q2 		$221K Buy
25,891
+872
+3% +$6.89K 0.01% 1256
2019
Q1 		$190K Sell
25,019
-260
-1% -$2.09K 0.01% 1330
2018
Q4 		$209K Sell
25,279
-7,943
-24% -$76K 0.01% 1270
2018
Q3 		$329K Buy
33,222
+111
+0.3% +$1.15K 0.01% 1255
2018
Q2 		$324K Sell
33,111
-464
-1% -$4.56K 0.01% 1249
2018
Q1 		$312K Sell
33,575
-7,981
-19% -$76K 0.01% 1238
2017
Q4 		$395K Sell
41,556
-33,965
-45% -$325K 0.01% 1171
2017
Q3 		$781K Buy
+75,521
New +$697K 0.02% 719
2016
Q3 		$781K Buy
+75,521
New +$480K 0.02% 719

Other funds holding SEM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Crossmark Global Holdings's SEM Position: Q4 2024 in Review

Crossmark Global Holdings sold out of Select Medical (SEM) in Q4 2024, closing a stake of 15,535 shares — an estimated $292K sold.

Crossmark Global Holdings first reported a position in SEM in Q3 2016 and held it in 30 quarters. The position peaked at $781K in Q3 2017. 271 funds tracked by Wall St. Rank hold SEM as of Q4 2024.

  • Crossmark Global Holdings reported no remaining Select Medical position as of Q4 2024 after selling out during the quarter.
  • Crossmark Global Holdings sold 15,535 Select Medical shares in Q4 2024, an estimated $292K.
  • Crossmark Global Holdings first reported a position in Select Medical in Q3 2016 and held it in 30 quarters.
  • Crossmark Global Holdings's Select Medical position peaked at $781K in Q3 2017.
  • 271 funds tracked by Wall St. Rank held Select Medical as of Q4 2024.

Based on Crossmark Global Holdings's 13F filing for Q4 2024, filed 16 Jan 2025.